Moderna: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Moderna
Largest movements
- Cash -€3,526
down €3,526 (-14.4%), from €24,539 to €21,013
mainly Net result for the year (-€3,188) and Receivables within one year (-€1,712)
- Receivables within one year +€1,712
up €1,712 (+18.4%), from €9,323 to €11,035
of which Other amounts receivable: +€1,595
- Profit (loss) carried forward -€3,188
down €3,188 (-39.6%), from -€8,041 to -€11,228
- Gross operating margin +€4,166
up €4,166 (+47.7%), from -€8,736 to -€4,570
- Depreciation -€820
down €820 (-43.7%), from €1,876 to €1,056
- Taxes +€591
up €591, from €0 to €591
- Other operating charges -€385
down €385 (-75.1%), from €513 to €128
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €149,714 | €146,844 | -€2,870 | -1.9% |
| Fixed assets | 21/28 | €5,952 | €4,896 | -€1,056 | -17.7% |
| Tangible fixed assets | 22/27 | €5,952 | €4,896 | -€1,056 | -17.7% |
| Furniture and vehicles | 24 | €0 | - | = | |
| Other tangible fixed assets | 26 | €5,952 | €4,896 | -€1,056 | -17.7% |
| Current assets | 29/58 | €143,763 | €141,948 | -€1,814 | -1.3% |
| Amounts receivable after more than one year | 29 | €109,900 | €109,900 | = | 0.0% |
| Other amounts receivable | 291 | €109,900 | €109,900 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €9,323 | €11,035 | +€1,712 | +18.4% |
| Trade receivables | 40 | €0 | €117 | +€117 | |
| Other amounts receivable | 41 | €9,323 | €10,918 | +€1,595 | +17.1% |
| Cash at bank and in hand | 54/58 | €24,539 | €21,013 | -€3,526 | -14.4% |
| Total equity and liabilities | 10/49 | €149,714 | €146,844 | -€2,870 | -1.9% |
| Equity | 10/15 | €147,183 | €143,995 | -€3,188 | -2.2% |
| Contributions | 10/11 | €21,815 | €21,815 | = | 0.0% |
| Reserves | 13 | €133,409 | €133,409 | = | 0.0% |
| Distributable reserves | 133 | €133,409 | €133,409 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€8,041 | -€11,228 | -€3,188 | -39.6% |
| Amounts payable | 17/49 | €2,531 | €2,849 | +€318 | +12.5% |
| Amounts payable within one year | 42/48 | €2,531 | €2,849 | +€318 | +12.5% |
| Trade debts | 44 | €373 | €0 | -€373 | -100% |
| Suppliers | 440/4 | €373 | €0 | -€373 | -100% |
| Taxes, remuneration and social security | 45 | €1,226 | €1,988 | +€763 | +62.2% |
| Taxes | 450/3 | €1,226 | €1,988 | +€763 | +62.2% |
| Other amounts payable | 47/48 | €933 | €861 | -€72 | -7.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,876 | €1,056 | -€820 | -43.7% |
| Other operating charges | 640/8 | €513 | €128 | -€385 | -75.1% |
| Gross operating margin | 9900 | -€8,736 | -€4,570 | +€4,166 | +47.7% |
| Operating profit (loss) | 9901 | -€11,125 | -€5,753 | +€5,372 | +48.3% |
| Financial income | 75/76B | €3,297 | €3,297 | = | 0.0% |
| Recurring financial income | 75 | €3,297 | €3,297 | = | 0.0% |
| Financial charges | 65/66B | €213 | €141 | -€73 | -34.0% |
| Recurring financial charges | 65 | €213 | €141 | -€73 | -34.0% |
| Profit (loss) for the period before taxes | 9903 | -€8,041 | -€2,597 | +€5,444 | +67.7% |
| Income taxes | 67/77 | €0 | €591 | +€591 | |
| Profit (loss) for the period | 9904 | -€8,041 | -€3,188 | +€4,853 | +60.4% |
| Profit (loss) for the period to be appropriated | 9905 | -€8,041 | -€3,188 | +€4,853 | +60.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.